Standout Papers

Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma 2024 202638
  1. Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma (2024)
    Nan Zhang, Yang Xu et al. Biomarker Research

Immediate Impact

39 standout
Sub-graph 1 of 20

Citing Papers

HER2-targeted therapies in cancer: a systematic review
2024 Standout
Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
2024 Standout
3 intermediate papers

Works of Yunchao Wang being referenced

Microarray expression profile analysis of circular RNAs in pancreatic cancer
2018
Hormone receptor status predicts the clinical outcome of human epidermal growth factor 2-positive metastatic breast cancer patients receiving trastuzumab therapy: a multicenter retrospective study
2015

Author Peers

Author Last Decade Papers Cites
Yunchao Wang 218 153 111 56 544
Michio Maemura 202 244 88 72 649
Sun-Jae Lee 163 105 121 51 635
Marek Cybulski 262 163 63 52 604
Hai Liao 255 126 39 49 625
Long Zhao 408 86 41 38 616
Serdar Bedii Omay 202 136 38 40 594
Shihui Li 255 49 109 48 642
Liwei Zhang 366 90 102 56 617
Vitalba Ruggieri 363 104 50 29 629
Tong Zhou 267 178 93 49 607

All Works

Loading papers...

Rankless by CCL
2026